PRESENTATION

Q4 2024 — Earnings presentation

Q4 2024PDF · 19 pages10.7 MB
Championing a Smoke-Free World
2024 Fourth-Quarter and
Full-Year Results
February 6, 2025
Introduction
• A glossary of terms as well as adjustments, other calculations and reconciliations to
the most directly comparable U.S. GAAP measures for non-GAAP financial measures
cited in this presentation are available in Exhibit 99.2 to the company's Form 8-K
dated February 6, 2025 and on our Investor Relations website with additional non-
GAAP reconciliations available at the end of this presentation
2

-- 1 of 19 --

Forward-Looking and Cautionary Statements
• This presentation contains projections of future results and goals and other forward-looking statements, including statements regarding expected
financial or operational performance; capital allocation plans; investment strategies; market expectations; regulatory outcomes; sustainability plans and
projections; business plans and strategies; and dividends. Achievement of future results is subject to risks, uncertainties and inaccurate assumptions. In
the event that risks or uncertainties materialize, or underlying assumptions prove inaccurate, actual results could vary materially from those contained in
such forward-looking statements. Pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, PMI is identifying
important factors that, individually or in the aggregate, could cause actual results and outcomes to differ materially from those contained in any
forward-looking statements made by PMI
• PMI's business risks include: excise tax increases and discriminatory tax structures; increasing marketing and regulatory restrictions that could reduce
our competitiveness, eliminate our ability to communicate with adult consumers, or ban certain of our products in certain markets or countries; health
concerns relating to the use of tobacco and other nicotine-containing products and exposure to environmental tobacco smoke; litigation related to
tobacco and / or nicotine use and intellectual property; intense competition; the effects of global and individual country economic, regulatory and
political developments, natural disasters and conflicts; the impact and consequences of Russia's invasion of Ukraine; changes in adult smoker behavior;
the impact of natural disasters and pandemics on PMI's business; lost revenues as a result of counterfeiting, contraband and cross-border purchases;
governmental investigations; unfavorable currency exchange rates and currency devaluations, and limitations on the ability to repatriate funds; adverse
changes in applicable corporate tax laws; adverse changes in the cost, availability, and quality of tobacco and other agricultural products and raw
materials, as well as components and materials for our electronic devices; and the integrity of its information systems and effectiveness of its data
privacy policies. PMI's future profitability may also be adversely affected should it be unsuccessful in its attempts to introduce, commercialize, and grow
smoke-free products or if regulation or taxation do not differentiate between such products and cigarettes; if it is unable to successfully introduce new
products, promote brand equity, enter new markets or improve its margins through increased prices and productivity gains; if it is unable to expand its
brand portfolio internally or through acquisitions and the development of strategic business relationships; if it is unable to attract and retain the best
global talent, including women or diverse candidates; or if it is unable to successfully integrate and realize the expected benefits from recent
transactions and acquisitions. Future results are also subject to the lower predictability of our smoke-free business’ performance
• PMI is further subject to other risks detailed from time to time in its publicly filed documents, including PMI’s Annual Report on Form 10-K for the
fourth quarter and year ended December 31, 2023 and the Form 10-Q for the quarter ended September 30, 2024, and the Form 10-K for the fourth
quarter and year ended December 31, 2024 which will be filed today. PMI cautions that the foregoing list of important factors is not a complete
discussion of all potential risks and uncertainties. PMI does not undertake to update any forward-looking statement that it may make from time to time,
except in the normal course of its public disclosure obligations
• References to “PMI”, “we”, “our” and “us” mean Philip Morris International Inc, including its subsidiaries
3
2024: Outstanding Year for Smoke-Free Transformation
• Very strong organic top and bottom-line growth across
all categories:
⎼ Fourth consecutive year of total volume growth
⎼ Continued IQOS growth momentum, increasing profitability
⎼ ZYN sequential volume acceleration
⎼ Strong combustible net revenue & profit growth
⎼ +15% organic OI growth, +10% in USD
• +9% USD Adj. diluted EPS growth, mitigating currency
headwinds with price and cost actions
• Strong cashflow generation and deleveraging
4
Source: PMI Financials or estimates

-- 2 of 19 --

10 Years of Smoke-Free Transformation
2024 Key Milestones
5
• Nearly $15bn smoke-free net revenues,
>$10bn total PMI adj. net earnings (a)
• Smoke-free net revenues 40% of total PMI
in Q4, ~60% in Top-5 OI markets (b)
• Multi-category strategy deployed in ~50%
of 95 smoke-free markets, >38.5m users
• >1bn oral smoke-free product(c) cans
(644m nicotine pouch cans)
• FDA authorization for all ZYN products
currently marketed by Swedish Match in
the U.S.
(a) Adjusted net earnings attributable to PMI. (b) Ranking based on FY’24 OI (c) Excluding snuff, snuff leaf and U.S. chew. Source: PMI Financials or estimates
Adj. Smoke-Free Net Revenues
($ billion)
0.2 0.9
3.8 4.2 5.7 6.9
9.3 10.2
12.814.7
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Note: Growth rates presented on an organic basis reflect currency-neutral adjusted results, excluding acquisitions. Shipment volume includes HTUs, cigarettes and oral SFPs excluding
snuff, snuff leaf and U.S. chew. Source: PMI Financials or estimates
FY24: Very Good Growth Across Key Metrics
6
Organic
Adj. incl.
Curr. & Acq.
Operating Cashflow 	$12.2 bn
Adj. Diluted EPS 	+15.6 % +9.3% $6.57
Operating Income 	+14.9 % +10.1% $14.7 bn
Shipment Volume 	+2.9 % 774 bn
Net Revenues 	+7.4%
+9.8 % $37.9 bn
FY’24 vs. PY
(Adjusted)
(Adjusted)
FY’24
(Curr. neutral)

-- 3 of 19 --

Adj. Diluted EPS
(Variance vs. PY)
Operating Income
(Variance vs. PY)
Net Revenues
(Variance vs. PY)
Shipment Volume
(Variance vs. PY)
Note: Growth rates presented on an organic basis reflect currency-neutral adjusted results, excluding acquisitions. Shipment volume includes HTUs, cigarettes and oral SFPs excluding
snuff, snuff leaf and U.S. chew. Source: PMI Financials or estimates
Q4: Very Good Growth Across Key Metrics
7
Organic
Adj. incl.
Curr. & Acq.
+9.6 % +14.0%
+11.8 % +15.3%
+7.3%
+2.3 %
Q4’24
+7.3 %
(Curr. neutral)
Strong Top-line Momentum, Accelerating Profit Growth
8
Note: Chart not to scale. Growth rates presented on an organic basis reflect currency-neutral adjusted results, excluding acquisitions. Source: PMI Financials or estimates
15.4%
10.1% 11.0%
15.6%
2021 	2022 	2023 	2024
Adj. Diluted EPS Growth
(Currency neutral vs. PY)
Net Revenue Growth
(Organic vs. PY)
7.6% 7.1% 7.8%
9.8%
2021 	2022 	2023 	2024

-- 4 of 19 --

Accelerated Smoke-Free & Combustibles Performance
9	(a) Represents Smoke-Free Business. Note: Organic gross margin growth is calculated based on organic gross profit, divided by organic net revenues. Chart not to scale. Growth rates
presented on an organic basis reflect currency-neutral adjusted results, excluding acquisitions. Source: PMI Financials or estimates
Net
Revenues
Gross
Profit
Operating
Income
12.7%
9.8%
Total PMI
Net
Revenues
Gross
Profit 22.7%
Smoke-Free(a) 	Combustibles
FY’24 Organic Growth vs. PY
Net
Revenues
Gross
Profit
14.9%
16.7%
+330bps
Smoke-Free
Gross Margin
5.9%
6.8%
+60bps
Combustible
Gross Margin
~$10bn
Gross Profit
FY’24
(a) Volumes shown in pouch or pouch equivalents, excluding snuff, snuff leaf and U.S. chew
Note: Total SFP volumes represent HTUs, Oral SFPs and VEEV volumes in equivalent units. Total may not foot due to rounding. Source: PMI Financials or estimates
Fourth Consecutive Year of Volume Growth
10
(shipments in bn units; change vs. PY)
612.9
125.3
14.0
Total 	752.2
Oral SFP(a)
HTUs
Cigarettes
2.9%
11.6%
0.6%
24.6%
12.6%
0.8%
Shipments 	Adj. IMS
774.0
616.8
139.7
17.4 	24.5%
3.1%	1.7bn
2.7x vs. PY
VEEV
Shipments
Total SFP
Shipments
+13.5%
2023 	2024
FY’24 vs. PY
incl. VEEV

-- 5 of 19 --

FY'24 Organic
Shipment
Volume
Organic
Net Revenue
Growth
FY'24 Adj.
Net Revenue
Growth
7.4%
Pricing
(Combustibles &
Smoke-Free(a))
9.8%
Currency &
Acquisitions
Top-Line Growth Powered by Volumes, Pricing & Category Mix
11	(a) Represents Smoke-Free Business. Note: Smoke-free mix represents the impact of an increased proportion of smoke-free products at higher net-revenue per unit and is calculated at
total PMI level, excluding the impact from market mix. Total may not foot due to rounding. Source: PMI Financials or estimates
2.9%
+1.9pp
+6.2pp
Smoke-Free
Mix Impact
(2.4)pp
(1.2)pp
Geographic Mix
& Other
2.2pp
Oral SFP
FY'23 	FY'24
SG&A
Gross Margin
39.6%
Currency &
Acquisitions
OI Margin Expansion While Investing For Growth
12
Note: Total may not foot due to rounding. Source: PMI Financials or estimates
37.8%
FY’24 Adjusted OI Margin
38.8%
+1.6pp
+0.2pp
(0.8)pp
FY’24
(excl. Curr. & Acq.)
+180bps 	+100bps

-- 6 of 19 --

20.6 	21.7 23.7 	25.1 27.4 	28.8 	30.7 	32.2
4.2
5.2 5.7
0.5
0.8 1.0
33.3
36.3 38.6
H1'21 	FY'21 	H1'22 	FY'22 	H1'23 	FY'23 	H1'24 	FY'24
(a) See Glossary for definition. (b) Total Smoke-Free Product Users are net of estimated poly-users across categories. Note: periods up until H1’23 include only IQOS and exclude Swedish
Match in FY’22 and H1’23. Source: PMI Financials or estimates and PMI Market Research
Over 38m Users of PMI Smoke-Free Products
13
Total Smoke-Free Product Users(a)
(in millions)
Estimated users who
have switched to IQOS
and stopped smoking(a) 	72%	71%	71% 	73% 	73%	71% 	72%
IQOS
Oral SFP
E-Vapor
Total Users(b)
72%
+5.3m
vs.PY
Continued IQOS HTU Momentum, Accelerating Profitability
14
IQOS Product Contribution(a)
(Indexed, 2020 =100)
Note: HTU Adj. IMS in 2020 and 2021 represent reported IMS. (a) At constant exchange rates. Product contribution calculated as gross profit minus commercial and R&D costs.
Source: PMI Financials or estimates
76
92
105
121
136
2020 	2021 	2022 	2023 	2024
HTU Adj. IMS
(billion units)
100
215 246
299
366
2020 	2021 	2022 	2023 	2024
+15bn
Average 2020-24
(incl. new
markets)

-- 7 of 19 --

11.1 11.6 12.0 12.4 	12.6 12.9 13.2 13.5
9.2% 	9.0% 8.7%
9.7% 10.2% 9.8% 9.5%
10.6%
Q1 	Q2 	Q3 	Q4 	Q1 	Q2 	Q3 	Q4
(a) Based on a four-quarter moving average. Source: PMI Financials or estimates
Europe: Broadening Growth Drivers, Underlying Momentum
15
Adj. IMS(a)
(in billion units)
2023
+9.4%
FY’24 vs. PY
Adj. IMS
HTU
Adj. SoM
2024
Impressive Progress in European Key Cities
16
	Source: PMI Financials or estimates
7.0% 	7.9% 	9.0% 	9.6% 	9.9% 12.0%
17.7% 18.8% 19.5% 21.7% 21.8%
27.2% 28.8% 30.1% 32.9%
40.7%
Stockholm Amsterdam 	Madrid 	Vienna 	London 	Munich 	Sofia 	Zurich 	Bucharest 	Warsaw 	Prague 	Lisbon 	Bratislava 	Rome 	Athens 	Budapest
+1.2pp +1.9pp +1.2pp +2.8pp 	(0.2)pp
PMI HTU Offtake Share (Q4’24)
(0.6)pp
Change vs. PY
+0.2pp +2.1pp 	+1.9pp 	+2.9pp	+3.4pp 	+3.0pp 	+3.5pp	+1.6pp 	+1.3pp	+1.2pp

-- 8 of 19 --

9.0 9.3 9.6 9.9 10.2 10.5 10.9 11.2
Japan: Continued Excellent IQOS Performance
17
26.2% 	26.3% 	26.5% 27.5%
29.2% 	29.4% 	29.9% 30.6%
Q1 	Q2 	Q3 	Q4 	Q1 	Q2 	Q3 	Q4
Adj. IMS(a)
(in billion units)
Japan HTU Offtake Share(b)
Q4’23 	Q4’24
Sendai
+2.4pp
32.1% 	34.5%
Tokyo
34.1% 	36.3%
+2.2pp
Fukuoka
+3.2pp
30.9% 34.1%
2023
(a) Based on a four-quarter moving average. (b) Based on 3 C-Store Chains offtake. Base includes cigarettes, cigarillos and HTUs. Source: PMI Financials or estimates
+13.2%
FY’24 vs. PY
Adj. IMS
HTU
Adj. SoM
2024
Sendai
Tokyo
Fukuoka
56.4%
51.7%
Nagoya
49.8%
Sapporo
49.3%
Saitama
Kumamoto
52.0%
Chiba
Kawasaki
52.8%
53.6%
52.3%
52.0%
Yokohama 	51.2%
Hamamatsu 	50.7%
Shizuoka 	50.6%
Category Penetration Surpassing 50% In Multiple Key Cities
18	(a) Based on 3 C-Store Chains offtake. Base includes cigarettes, cigarillos and HTUs
Source: PMI Financials or estimates
Dec’24 Offtake HnB Category Share(a)
47.1%
National
+4.1pp vs. PY
+2 cities vs. Sep’24

-- 9 of 19 --

19
2.9% 4.0% 	4.2% 	4.3% 	4.4% 	4.5% 	4.7% 	5.3%
8.8%
12.9% 	13.3%
15.6% 	16.1%
18.9%
Toronto Mexico City 	Manila 	Tunis 	Bogota 	Riyadh 	Rabat 	Urban
Jakarta
Cairo 	Kuala
Lumpur
Seoul 	Belgrade 	Duty Free
(Airports)
Podgorica
+2.6pp 	+1.8pp 	(0.6)pp
PMI HTU Offtake Shares (Q4’24)
+2.0pp
Change vs. PY
+1.1pp 	+3.1pp 	+3.4pp	+0.5pp 	+1.2pp
(a) Duty Free includes airports where IQOS is available, offtake share based on Sep-Nov’24 vs. Sep-Nov’23.
Note: Urban Jakarta represents West, Central and South Jakarta which include an estimated 1.5 million Legal Age Nicotine Users. Cairo represents Urban Cairo, Manila represents Metro
Manila, Tunis represents Greater Tunis. Source: PMI Financials or estimates
+1.0pp
Strong Key City Growth Across Global Markets
+0.6pp 	+1.3pp 	+1.1pp 	+3.2pp
(a)
U.S. IQOS ‘Be The First’ Campaign Continues
20

-- 10 of 19 --

50 59 	64 	65 73
90
105 116 132 135 
149
165
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
Source: PMI Financials or estimates, Circana, LLC, Nicotine Pouches, Week ending 12/29/24
Strong ZYN Demand, Sequential Volume Acceleration
21
U.S. Nicotine Pouch Category Volume Share
(4-week period, %)
2024	2023
Q1 	Q2 	Q3 	Q4 	Q1 	Q2
2022
ZYN U.S. Shipment Volumes
(million cans)
Q3
66.5%
73.2%
64.7% 	65.5%
65.9%
18.8%
7.1%
3.5%
0%
5%
10%
15%
20%
25%
30%
35%
40%
45%
50%
55%
60%
65%
70%
75%
72.4%
ZYN
Retail Value Share
Q4’24
(13-week period)
ZYN
Competitor 1
Competitor 2
Competitor 3
2023 	2024
Q4
ZYN Leading Category Growth Again Despite Constraints
22
Source: PMI Financials or estimates, Circana, LLC, Nicotine Pouches, Week ending 12/29/24
ZYN and U.S. Nicotine Pouch Category
(Offtake sequential volume change, %)
11%
20% 17% 	16% 17%
-3%
1%
9%
10%
18% 12% 	13% 	15%
5% 	6% 	7%
Q1 	Q2 	Q3 	Q4 	Q1 	Q2 	Q3 	Q4
2023
ZYN 	U.S. Nicotine Pouch Category
2024
• Category trends driven by ZYN
• Stronger demand limits progress
in retail availability:
⎼ Production capacity continues to
grow
⎼ Target full normalization in H2’25
• Well-positioned for strong growth
• First and only FDA-authorized
nicotine pouch brand

-- 11 of 19 --

(a) Markets where PMI commercializes nicotine pouches, including U.S.
Source: PMI Financials or estimates
Increasing Growth Contribution from ZYN Internationally
23
9.6
Q4'24
37
Global Markets(a)
International Nicotine Pouch
Shipment Volumes
(growth vs. PY, million cans)
27.2
FY'24
+75%
vs. PY
+9
Q4’24 vs. PY
(a) Based on Sep-Nov’24 offtake volumes. (b) Italy and Czech Republic based on Nielsen, Italy including tobacco shops only. France based on Strator.
Source: PMI Financials or estimates
Very Good VEEV Traction in Key Geographies
24
Italy
100 267
Q4'23 	Q4'24
Czech Republic
• Increasingly contributing to multi-
category offer, generating incremental
growth
• Top-3 pod brand in 13 European
markets(a):
VEEV ONE Offtake Volumes(b)
(Indexed, Q4’23 =100)
100 249
Q4'23 	Q4'24
France
100 278
Q4'23 	Q4'24
Belgium 	Czech Rep. 	Estonia 	Finland
France 	Germany 	Greece 	Italy 	Poland
Portugal 	Romania 	Slovakia
1 st 	1 st
1 st
1 st	1 st
Bulgaria

-- 12 of 19 --

Combustibles: Strong Pricing & Efficiencies Drive Profitability
25
(a) Pricing variance is based on adjusted net revenues. Source: PMI Financials or estimates
2.7 5.0
8.9 	8.7
2021 	2022 	2023 	2024
Combustible Pricing
(% organic growth vs. PY)(a)
• Growing total industry, essentially
driven by markets where SFPs are
banned:
⎼ Secular declines persist elsewhere
• Maximizing value with pricing and
cost efficiencies
• Strong performance from Marlboro
and global brands
Combustible Gross Profit
(% organic growth vs. PY)
0.5 	1.9 	0.3
6.8
2021 	2022 	2023 	2024
(a) Includes cigarettes and SFP volumes. (b) Includes HTUs, e-vapor unit equivalents and oral SFP in pouch or pouch equivalents, excluding snuff, snuff leaf and U.S. chew. (c) On an
organic basis. (d) Currency neutral variance. (e) At prevailing rates. Source: PMI Financials or estimates
2025: Another Year of Superior Growth Expected
• Adjusted diluted EPS forecast of
$7.04 -7.17 incl. unfavorable
currency impact of 22 cents(e)
⎼ Includes Q1 forecast of $1.58-1.63
with 4 cents of unfavorable
currency(e)
26
2025 Outlook
Up to 2%	Total Shipment Volumes(a)
12-14 %	SFP Shipment Volumes(b)
10-12 %	HTU Adj. IMS Growth
780-820 m	U.S. ZYN Shipment Volumes, (cans)
6-8 %	Net Revenue Growth(c)
10.5-12.5 %	Adj. OI Growth (c)
10.5-12.5 %	Adj. Diluted EPS Growth(d)
7-9 %	Adj. Diluted EPS Growth, USD(e)

-- 13 of 19 --

Adj. Diluted EPS
(Currency Neutral Variance vs. PY)
Operating Income
(Variance vs. PY)
Net Revenues
(Variance vs. PY)
Shipment Volume
(Variance vs. PY)
Note: Growth rates presented on an organic basis reflect currency-neutral adjusted results, excluding acquisitions/divestitures. Shipment volume for 2024 and 24-26 CAGR targets
includes HTUs, cigarettes and oral SFPs excluding snuff, snuff leaf and U.S. chew. 2025 forecast also includes e-vapor. (a) At 2023 corporate income tax rates.
Source: PMI Financials or estimates
Delivering Best-in-Class CPG Performance
27
+15.6%
+14.9%
+9.8%
+2.9%
FY’24
Organic
2024-26 CAGR
Targets
+9-11%(a)
+8-10%
+6-8%
Positive
Organic
+10.5-12.5%
+10.5-12.5%
+6-8%
Up to 2%
2025 Forecast
Organic
(a) As of December 31, on a 12-month rolling basis. (b) At prevailing rates, subject to year-end working capital requirements.
Note: Operating cash flow is defined as net cash provided by operating activities. Source: PMI Financials or estimates
Highly Cash Generative With Focus on Deleveraging
28
Net Debt to Adjusted EBITDA Ratio(a)
2.04 1.91 1.93 1.62
2.89 3.16
2.66
2018 	2019 	2020 	2021 	2022 	2023 	2024
• Expect strong 2025 operating cash flow of
~$11bn, broadly in line with 2024 before
non-recurring tax and Germany payments(b)
• Investing in innovation and growth:
⎼ Capital expenditures of around $1.5 billion
• Unwavering commitment to progressive
dividend
• Continue to target ~2.0x net debt to
adjusted EBITDA by end of 2026, with
further improvement in 2025

-- 14 of 19 --

Outstanding 2024 Delivery, Very Strong 2025 Expected
29
• Powerful combination of underlying momentum and
proactive steps supports best-in-class growth profile:
⎼ Structural smoke-free top-line growth with superior
economics
⎼ Investing for growth while driving profitability through
mix, pricing, scale and efficiencies
• Smoke-free transformation delivering meaningful
value for shareholders:
⎼ Broad-based performance drives cash generation
⎼ 17y of dividend growth, committed to shareholder returns
Source: PMI Financials or estimates
Championing a Smoke-Free World
Questions & Answers
iOS Download 	Android Download	Have you downloaded the PMI Investor Relations App?
The free IR App is available to download at the Apple App Store
for iOS devices and at Google Play for Android mobile devices
Or go to: www.pmi.com/irapp
2024 Fourth-Quarter and
Full-Year Results

-- 15 of 19 --

Championing a Smoke-Free World
2024 Fourth-Quarter and
Full-Year Results
February 6, 2025
Championing a Smoke-Free World
32
Appendix and
Reconciliation of Non-GAAP Measures

-- 16 of 19 --

Approximate Impact of Currency on 2024 EPS
33
Source: PMI Financials or estimates
FY 2024
$(0.19)	Japanese Yen
$(0.14)	Egyptian Pound
$(0.07)	Russian Ruble
$(0.04)	Euro
$0.18	Argentine Peso
$(0.12)	Others
$(0.38)
Total PMI
Currency Impact
($/share)
(a) See forecast assumptions in Earnings Release for details
Source: PMI Financials or estimates
2025: EPS Guidance
Growth	2024
2025
Forecast
$4.52	$6.55 – $6.68	Reported Diluted EPS
Adjustments:
0.10	-	- Restructuring charges
0.01	-	- Impairment of goodwill and other intangibles
0.40	0.49	- Amortization of Intangibles(a)
0.13	-	- Loss on sale of Vectura Group
0.03	-	- Egypt sales tax charge
0.05	-	- Megapolis localization tax impact
0.14	-	- Income tax impact associated with Swedish Match AB financing
1.49	-	- Impairment related to the RBH equity investment
(0.27)	-	- Fair value adjustment for equity security investments
(0.03)	-	- Tax items
2.05	0.49	- Total Adjustments
7.2% – 9.1%	$6.57	$7.04 – $7.17	Adjusted Diluted EPS
(0.22)	- Less: Currency
10.5% –12.5%	$6.57	$7.26 – $7.39	Adjusted Diluted EPS, excluding currency
34
Full-Year	($/share)

-- 17 of 19 --

Select European Markets: PMI HTU Adjusted Share of Market
Change
vs. PY	FY’24
Change
vs. PY	FY’24
Change
vs. PY	FY’24
+1.2pp	17.2%
Slovak
Republic	+0.1pp	16.9%	Italy	+1.2pp	8.3%	Austria
+2.0	14.3	Slovenia	+0.3	28.1	Lithuania	-	14.9
Czech
Republic
+0.5	2.8	Spain	+0.1	9.1	Poland	+0.9	6.2	Germany
+1.3	12.8	Switzerland	+2.4	20.6	Portugal	+2.3	21.8	Greece
+1.1	4.6
United
Kingdom	+1.1	8.9	Romania	+3.4	32.3	Hungary
35
Source: PMI Financials or estimates
36
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Reconciliation of Non-GAAP Measures
Reconciliation of Net Earnings attributable to PMI to Adjusted Net Earnings attributable to PMI
($ in millions) / (Unaudited)
(a) Represents adjustments impacting 2023 only: South Korea indirect tax charge ($174 million), Termination of agreement with Foundation for a Smoke-Free World ($111 million), Termination of distribution
arrangement in the Middle East ($70 million), Charges related to the war in Ukraine ($43 million), and Swedish Match AB acquisition accounting related items ($13 million). Source: PMI Financials or estimates
Net Earnings attributable to PMI 	$ 7,057 	$ 7,813 	(9.7)% 	(2.2)% 	(756) 	(594) 	9 	2,203 	764 	(3,138)
Restructuring charges 	(150) 	(96) 	(56.3)% 	(56.3)% 	(54) 	- 	- 	- 	- 	(54)
Impairment of goodwill and other intangibles 	(20) 	(678) 	97.1% 	97.1% 	658 	- 	- 	- 	- 	658
Amortization of intangibles 	(629) 	(389) 	(61.7)% 	(61.7)% 	(240) 	- 	- 	- 	- 	(240)
Megaplis localization tax impact 	(77) 	- 	- 	- 	(77) 	- 	- 	- 	- 	(77)
Income tax impact associated with Swedish Match AB financing 	(209) 	170 	-(100)% 	-(100)% 	(379) 	- 	- 	- 	- 	(379)
Egypt sales tax charge 	(39) 	- 	- 	- 	(39) 	- 	- 	- 	- 	(39)
Loss on sale of Vectura Group 	(206) 	- 	- 	- 	(206) 	- 	- 	- 	- 	(206)
Impairment related to the RBH equity investment 	(2,316) 	- 	- 	- 	(2,316) 	- 	- 	- 	- 	(2,316)
FV Adjustment for equity security investments 	418 	38 	+100% 	+100% 	380 	- 	- 	- 	- 	380
Tax items 	47 	(173) 	+100% 	+100% 	220 	- 	- 	- 	- 	220
Other adjustments impacting 2023 only (a) 	- 	(411) 	+100% 	+100% 	411 	- 	- 	- 	- 	411
Adjusted Net Earnings attributable to PMI 	$ 10,238 	$ 9,352 	9.5% 	15.7% 	886 	(594) 	9 	2,203 	764 	(1,496)
Price 	Vol/
Mix
Cost/
Other
Years ended
December 31,
Change
Fav./(Unfav.)
Variance
Fav./(Unfav.)
2024 	2023 	Total 	Excl.
Curr. & Acquis. 	Total 	Currency Acquisitions

-- 18 of 19 --

Championing a Smoke-Free World
2024 Fourth-Quarter and
Full-Year Results
February 6, 2025

-- 19 of 19 --